Experience with sorafenib and the elderly patient-Reference-Cited by-同舟云学术

Experience with sorafenib and the elderly patient

Published:2009-12-31 Issue:4 Volume:27 Page:1359-1370
ISSN:1357-0560
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Dutcher Janice P.,Tannir Nizar,Bellmunt Joaquim,Escudier Bernard

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12032-009-9388-4.pdf

Reference50 articles.

1. Wilkins M. Cancer in the elderly patient. In: Pathy MSJ, Sinclair AJ, Morley JE, editors. Principles and Practices of Geriatric Medicine. Chichester: Wiley; 1991. p. 1385–96.

2. National Cancer Institute SEER Database. Cancer: renal and kidney pelvis. 2009. Available at: http://www.seer.cancer.gov./statfacts/html/kidrp.html . Accessed 16 Feb 2009.

3. Martin JE, Sheaff MT. The pathology of ageing: concepts and mechanisms. J Pathol. 2007;211:111–3.

4. Bellmunt J, et al. The medical treatment of metastatic renal cell cancer in the elderly: position paper of a SIOG Taskforce. Crit Rev Oncol Hematol. 2009;69:64–72.

5. Coebergh JW, Janssen-Heijnen ML, Post PN, Razenberg PP. Serious co-morbidity among unselected cancer patients newly diagnosed in the southeastern part of The Netherlands in 1993–1996. J Clin Epidemiol. 1999;52:1131–6.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improved prognosis for elderly patients with metastatic renal cell carcinoma in the era of targeted therapy;Molecular and Clinical Oncology;2020-03-24

2. Significance of Age in Japanese Patients Receiving Sunitinib as First-line Systemic Therapy for Metastatic Renal Cell Carcinoma: Comparative Assessment of Efficacy and Safety between Patients Aged <75 and ≥75 Years;Anticancer Research;2018-05-30

3. Efficacy and safety of axitinib in elderly patients with metastatic renal cell carcinoma;Medical Oncology;2016-07-21

4. Therapeutic effects and associated adverse events of multikinase inhibitors in metastatic renal cell carcinoma: A meta-analysis;Experimental and Therapeutic Medicine;2015-04-15

5. GOAL: An inverse toxicity-related algorithm for daily clinical practice decision making in advanced kidney cancer;Critical Reviews in Oncology/Hematology;2014-03